Myocardial dysfunction in an animal model of cancer cachexia. - Wikidata - awgldk - TriplyDB

Myocardial dysfunction in an animal model of cancer cachexia.

Myocardial dysfunction in an animal model of cancer cachexia.

http://www.wikidata.org/entity/Q34670626

about

Tumor growth increases neuroinflammation, fatigue and depressive-like behavior prior to alterations in muscle function.Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist.Fluoxetine prevents the development of depressive-like behavior in a mouse model of cancer related fatigue Storage Conditions and Passages Alter IL-6 secretion in C26 adenocarcinoma cell lines.Ubiquinol reduces muscle wasting but not fatigue in tumor-bearing mice Losartan treatment attenuates tumor-induced myocardial dysfunction Metalloproteinase expression is altered in cardiac and skeletal muscle in cancer cachexia Ibuprofen ameliorates fatigue- and depressive-like behavior in tumor-bearing mice.Nutritional leucine supplementation attenuates cardiac failure in tumour-bearing cachectic animals.Cancer cachexia update in head and neck cancer: Definitions and diagnostic features.Developing models for cachexia and their implications in drug discovery.Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.Establishment and characterization of a novel murine model of pancreatic cancer cachexia.Pay attention to cardiac remodeling in cancer cachexia.Tumor inoculation site affects the development of cancer cachexia and muscle wasting.Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.Cardiac and skeletal muscles show molecularly distinct responses to cancer cachexia.Formoterol in the treatment of experimental cancer cachexia: effects on heart function Minocycline attenuates cardiac dysfunction in tumor-burdened mice.Prostate cancer reduces endurance exercise capacity in association with reductions in cardiac and skeletal muscle mass in the rat.Cardiac muscle wasting in individuals with cancer cachexia.Increased hypoxia-inducible factor-1α in striated muscle of tumor-bearing mice.Subcutaneous Ehrlich Ascites Carcinoma mice model for studying cancer-induced cardiomyopathy.

P2860

Q27331924-C813CEA2-DF7E-4663-943C-02BD4C8317FA Q28068034-6BF6FA15-A13E-47AD-BE56-DEDF4E86754F Q33741091-F978B177-0B19-469A-8443-A407D33F7B55 Q34982978-FBDE47CC-00C1-40EE-A786-6D4A7F5EFD35 Q35104200-A51FF769-44D4-4C56-BBBA-1D19B95D36F0 Q35186185-968B8DD0-7598-4938-B0C4-61125DB083F9 Q35931497-78349AB6-2873-40D6-87D7-0F7E63825949 Q35958613-1D7DBBB6-18D7-4E6D-B4E2-3FD3B8AC1531 Q36373115-006630B5-A168-40DB-983A-1205BAB2CD3C Q36692110-5DB0FA55-0B4C-40FA-A5E5-98D9F054C029 Q38177750-247DD643-6DDB-4174-81D0-E86F5BE1FB0E Q38451282-41B5FC0A-3924-4CA6-ABAF-BD22C226EA0D Q38628641-4BBDE316-B250-4D73-8014-723343E90F53 Q38653925-B32E7F86-49A0-478A-9F69-EFFE5E83A3F2 Q38815915-AA9F590D-9EEB-4E6A-BB16-2AEDD261EDB1 Q38870440-65E31935-127E-4DE0-A015-A291D35F7A48 Q39726480-F3C5C940-F97E-4027-B8BE-B1FC4D3B2E2A Q40987037-7BAB3E84-91C5-4662-B976-9A7366D51E7B Q42062172-A465DE78-051F-4D04-B5C7-1A0D9588854A Q42860182-1B09E283-1E9D-4F9C-A92A-C43C59C7FC37 Q47214314-76A5ED65-488B-41AF-87B4-CE26FCE77722 Q47445814-755420C0-429B-4552-8683-6170B7B076E8 Q47938781-4A410CCB-31B9-4E40-ACF5-2839DA1A3286 Q55002400-0A361075-748F-4431-B8B6-51183BB4D1FE

P2860

Myocardial dysfunction in an animal model of cancer cachexia.

http://www.wikidata.org/entity/Q34670626

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Myocardial dysfunction in an animal model of cancer cachexia.

@ast

Myocardial dysfunction in an animal model of cancer cachexia.

@en

Myocardial dysfunction in an animal model of cancer cachexia.

@nl

type

label

Myocardial dysfunction in an animal model of cancer cachexia.

@ast

Myocardial dysfunction in an animal model of cancer cachexia.

@en

Myocardial dysfunction in an animal model of cancer cachexia.

@nl

prefLabel

Myocardial dysfunction in an animal model of cancer cachexia.

@ast

Myocardial dysfunction in an animal model of cancer cachexia.

@en

Myocardial dysfunction in an animal model of cancer cachexia.

@nl

P1433

Q34670626-70C617C2-BACF-4CE6-81B9-1F09E603E700

P1476

Q34670626-44A92D23-20F7-411C-83B5-6A9E2140303F

P2093

Q34670626-2DC450EA-E2AB-42E9-AA6E-450E17EE16A0

Q34670626-653CA175-F047-4E2B-964B-88991CF7C94F

Q34670626-701C1B54-D204-4F79-807B-0196986BD74F

Q34670626-7511A703-2ACF-42D3-B81B-69925041C423

Q34670626-76DF2B51-7B1B-4549-89B6-60D1289BA152

Q34670626-9B33AE73-57D3-4651-AB23-AF1FB2D6F826

Q34670626-C25ACCF9-66D0-4614-A418-CA1F00A16851

Q34670626-F5FB59A2-1F5E-4B35-9A1A-7A1CD6DD6E17

P2860

Q34670626-00EC31DB-B255-4ACB-B211-1AB949E0A15E

Q34670626-05C1B34C-F01E-4632-9AAA-98E9182E3009

Q34670626-082DF67E-9404-44F3-8488-A4E06122F0F4

Q34670626-552A540A-06AA-458D-95E3-F393084948C3

Q34670626-6094D60C-B84D-494F-9D4C-9187DCF68E2C

Q34670626-71081222-2FE7-4208-BB55-E3F1673125F3

Q34670626-85D0331E-B0D8-4073-A9AC-5A7FF555D997

Q34670626-8DD07BBC-86C3-4CF5-8C8D-E4257383C259

Q34670626-97CEE7F4-5FC6-45CB-8381-4F327B7D5B3E

Q34670626-9C94702B-9695-440F-A656-206E3D2BF8DC

P304

Q34670626-4E66270A-B688-4EE0-BB1E-5B39953B25D3

P31

Q34670626-1D9ADD72-A928-4F01-B28A-01B1B4C82B65

P356

Q34670626-6EA21188-3806-47D4-8F88-7C16D27E6B1F

P407

Q34670626-0050C758-B610-4A87-B297-305C043F8435

P433

Q34670626-4E0B3373-9DCA-4BB0-BBF7-C8DD49CDB452

P478

Q34670626-AAD716D6-361B-4C89-B8C1-62421B0DAA31

P577

Q34670626-9BDB7C48-EB7F-406C-9E98-6C93AA43BFC4

P5875

Q34670626-367E9F09-EFA4-4D55-8857-CFCB5EC49166

P698

Q34670626-8A282A50-E511-4A73-83D3-175EEBEE3F85

P932

Q34670626-F86E690B-56C5-4491-A506-2B64CC9A9002

P356

J.LFS.2010.12.010

P1433

P1476

Myocardial dysfunction in an animal model of cancer cachexia.

@en

P2093

Dane J Youtz

http://www.w3.org/2001/XMLSchema#string

Danielle Crawford

http://www.w3.org/2001/XMLSchema#string

Donna O McCarthy

http://www.w3.org/2001/XMLSchema#string

Hui Xu

http://www.w3.org/2001/XMLSchema#string

Kirk R Hutchinson

http://www.w3.org/2001/XMLSchema#string

Loren E Wold

http://www.w3.org/2001/XMLSchema#string

Markus Velten

http://www.w3.org/2001/XMLSchema#string

Pamela A Lucchesi

http://www.w3.org/2001/XMLSchema#string

P2860

Autophagy in the Pathogenesis of Disease

FoxO3 controls autophagy in skeletal muscle in vivo

Redox balance and carbonylated proteins in limb and heart muscles of cachectic rats.

Mechanisms of cancer cachexia.

Pathophysiology of cancer-related fatigue

Cancer cachexia signaling pathways continue to emerge yet much still points to the proteasome.

Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice

During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation.

Cancer fatigue syndrome reflects clinically non-overt heart failure: an approach towards onco-cardiology.

Powerful signals for weak muscles.

P304

406-410

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.LFS.2010.12.010

http://www.w3.org/2001/XMLSchema#string

P407

P433

9-10

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49691933

http://www.w3.org/2001/XMLSchema#string

P698

21167183

http://www.w3.org/2001/XMLSchema#string

P932

3057126

http://www.w3.org/2001/XMLSchema#string